Delivery Order SPE2DB24D2101-SPE2DB25FKMUX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,082.53 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $26,079.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pens on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency awarded a $10,019.57 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens (0.5 ml units). This competitively awarded, firm fixed-price contract will be completed by July 21, 2025, with performance taking place at the vendor's Corporate Office in Conshohocken, Pennsylvania. The award represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,994.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors. This competitive award, with no set-aside designation, is scheduled for completion by July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,448.81 on July 21, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections. This is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, to be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. As a child contract action, this delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,431.03 delivery order on July 25, 2025, for Mounjaro 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,496.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 ml pens on July 22, 2025, with an ultimate completion date of July 23, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order valued at $2,192.78 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pens on July 23, 2025, with an ultimate completion date of July 24, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $3,537.17 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro (tirzepatide) 5 mg/0.5 mL pens in 0.5 mL unit doses. The contract, which is a non-set-aside competitive award with an ultimate completion date of July 25, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,607.06 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. This competitively awarded, firm fixed price contract was executed on July 24, 2025, with an ultimate completion date of July 25, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMUXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,809.26 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This non-competitive delivery order utilizes firm fixed pricing and is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's federal contract portfolio demonstrates extensive capability across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. This delivery order for Mounjaro, a diabetes medication, exemplifies the company's role in supplying brand-name pharmaceuticals to support Defense Health Agency operations and other government healthcare systems through the DLA's flexible and comprehensive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 7/28/25 |